HepAssis2® bioartificial liver system in treating acute‐on‐chronic liver failure patients: Findings from a phase 1 randomised, open‐label clinical trial.
Saved in:
| Title: | HepAssis2® bioartificial liver system in treating acute‐on‐chronic liver failure patients: Findings from a phase 1 randomised, open‐label clinical trial. |
|---|---|
| Authors: | Zhong, Zibiao1 (AUTHOR), Liang, Wenjin1 (AUTHOR), Dai, Yong'an1 (AUTHOR), Xue, Chengbiao1 (AUTHOR), Zhou, Dawei1 (AUTHOR), Xu, Zhigao1 (AUTHOR), Li, Ling1 (AUTHOR), Pan, Li1 (AUTHOR), He, Chongxiang1 (AUTHOR), Zhou, Xin1 (AUTHOR), Zhou, Wei1 (AUTHOR), Zhou, Lihua1 (AUTHOR), Liu, Zhongzhong1 (AUTHOR), Xia, Zhiping1 (AUTHOR), Fan, Xiaoli1 (AUTHOR), Peng, Guizhu1 (AUTHOR), Wang, Yanfeng1 (AUTHOR), Zhou, Ping2 (AUTHOR) pzhou@tjh.tju.edu.cn, Ye, Shaojun1 (AUTHOR) 86987100@qq.com, Ye, Qifa1 (AUTHOR) yqf_china@163.com |
| Source: | Clinical & Translational Medicine. Feb2026, Vol. 16 Issue 2, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.70620 |
